BoxSPINE Secures FDA Clearance for DUET™ System, Introducing a New Era in Spinal Fixation BoxSPINE, LLC has announced a significant milestone with the U.S. Food and Drug Administration (FDA) granting…
TriSalus Life Sciences to Present New Data at SIR 2026 Annual Scientific Meeting TriSalus Life Sciences, Inc., a clinical-stage oncology company focused on improving outcomes for patients with solid tumors,…
Healthpeak Properties, Inc. Announces Q1 2026 Earnings Release and Investor Call Details Healthpeak Properties, Inc., a prominent real estate investment trust (REIT) specializing in properties that support healthcare discovery and…
Veradigm Strengthens Leadership with Appointment of Christian Greyenbuhl as Chief Financial Officer Veradigm Inc. (OTCMKTS: MDRX), a prominent provider of clinical, financial, and data-driven solutions designed to support independent healthcare…
GenSight Biologics Reports Q1 2026 Cash Position and Early Access Program Revenue Update GenSight Biologics, a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapies targeting retinal…
Stoke Therapeutics Strengthens Board with Appointment of Dr. Clare Kahn Stoke Therapeutics, Inc., a biotechnology company focused on transforming the treatment landscape for genetic diseases, has announced the appointment of…
ForSight Robotics Achieves Historic First-in-Human Fully Robot-Assisted Cataract Surgery ForSight Robotics has announced a historic milestone in the evolution of eye care: the successful completion of the world’s first fully…
Avant Healthcare Professionals Expands “Dream. Become. Inspire.” Nursing Scholarship Worldwide Avant Healthcare Professionals has announced a major expansion of its flagship “Dream. Become. Inspire.” Nursing Scholarship program, extending its reach…
Zentist to Host Dental RCM Bootcamp 6.0 in Nashville, Bringing Together Industry Leaders for Advanced Revenue Cycle Insights Zentist has officially announced that its highly anticipated Dental RCM Bootcamp 6.0…
Cencora to Release Second Quarter Fiscal 2026 Results on May 6, 2026 Cencora, Inc. has officially announced the date and time for the release of its financial results for the…
Alto Neuroscience Shares Phase 2 Results for ALTO-101 and Refocuses Pipeline Strategy Alto Neuroscience, Inc., a clinical-stage biopharmaceutical company dedicated to developing precision medicines for neuropsychiatric disorders, has released topline…
Frontier Medicines and LG Chem Forge Strategic Global Partnership for First-in-Class p53 Y220C Activator FMC-220 Frontier Medicines Corporation has entered into a landmark exclusive licensing agreement with LG Chem, Ltd.…